Nervous System Markers - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511248835

Publication Date:

November 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
The global market for Nervous System Markers was estimated to be worth US$ 543.6 million in 2023 and is forecast to a readjusted size of US$ 808.7 million by 2030 with a CAGR of 6.1% during the forecast period 2024-2030
According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China's drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has risen to a national strategy; from the perspective of industry policy, it has experienced the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the expansion of the drug reimbursement catalog The update will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nervous System Markers, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Nervous System Markers by region & country, by Type, and by Application.
The Nervous System Markers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nervous System Markers.
麻豆原创 Segmentation
By Company
Athena Diagnostics
Myriad RBM
QIAGEN
Thermo Fisher Scientific
Segment by Type:
Imaging Biomarkers
Metabolomics Biomarkers
Proteomic Biomarkers
Genomics Biomarkers
Segment by Application
Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Depression
Schizophrenia
Huntington's Disease
Parkinson's Disease
Alzheimer's Disease
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nervous System Markers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Nervous System Markers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Nervous System Markers in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Nervous System Markers Product Introduction
1.2 Global Nervous System Markers 麻豆原创 Size Forecast
1.2.1 Global Nervous System Markers Sales Value (2019-2030)
1.2.2 Global Nervous System Markers Sales Volume (2019-2030)
1.2.3 Global Nervous System Markers Sales Price (2019-2030)
1.3 Nervous System Markers 麻豆原创 Trends & Drivers
1.3.1 Nervous System Markers Industry Trends
1.3.2 Nervous System Markers 麻豆原创 Drivers & Opportunity
1.3.3 Nervous System Markers 麻豆原创 Challenges
1.3.4 Nervous System Markers 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nervous System Markers Players Revenue Ranking (2023)
2.2 Global Nervous System Markers Revenue by Company (2019-2024)
2.3 Global Nervous System Markers Players Sales Volume Ranking (2023)
2.4 Global Nervous System Markers Sales Volume by Company Players (2019-2024)
2.5 Global Nervous System Markers Average Price by Company (2019-2024)
2.6 Key Manufacturers Nervous System Markers Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Nervous System Markers Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nervous System Markers
2.9 Nervous System Markers 麻豆原创 Competitive Analysis
2.9.1 Nervous System Markers 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Nervous System Markers Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Markers as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Imaging Biomarkers
3.1.2 Metabolomics Biomarkers
3.1.3 Proteomic Biomarkers
3.1.4 Genomics Biomarkers
3.2 Global Nervous System Markers Sales Value by Type
3.2.1 Global Nervous System Markers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nervous System Markers Sales Value, by Type (2019-2030)
3.2.3 Global Nervous System Markers Sales Value, by Type (%) (2019-2030)
3.3 Global Nervous System Markers Sales Volume by Type
3.3.1 Global Nervous System Markers Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Nervous System Markers Sales Volume, by Type (2019-2030)
3.3.3 Global Nervous System Markers Sales Volume, by Type (%) (2019-2030)
3.4 Global Nervous System Markers Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Spinal Muscular Atrophy (SMA)
4.1.2 Multiple Sclerosis
4.1.3 Depression
4.1.4 Schizophrenia
4.1.5 Huntington's Disease
4.1.6 Parkinson's Disease
4.1.7 Alzheimer's Disease
4.2 Global Nervous System Markers Sales Value by Application
4.2.1 Global Nervous System Markers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nervous System Markers Sales Value, by Application (2019-2030)
4.2.3 Global Nervous System Markers Sales Value, by Application (%) (2019-2030)
4.3 Global Nervous System Markers Sales Volume by Application
4.3.1 Global Nervous System Markers Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Nervous System Markers Sales Volume, by Application (2019-2030)
4.3.3 Global Nervous System Markers Sales Volume, by Application (%) (2019-2030)
4.4 Global Nervous System Markers Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Nervous System Markers Sales Value by Region
5.1.1 Global Nervous System Markers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nervous System Markers Sales Value by Region (2019-2024)
5.1.3 Global Nervous System Markers Sales Value by Region (2025-2030)
5.1.4 Global Nervous System Markers Sales Value by Region (%), (2019-2030)
5.2 Global Nervous System Markers Sales Volume by Region
5.2.1 Global Nervous System Markers Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Nervous System Markers Sales Volume by Region (2019-2024)
5.2.3 Global Nervous System Markers Sales Volume by Region (2025-2030)
5.2.4 Global Nervous System Markers Sales Volume by Region (%), (2019-2030)
5.3 Global Nervous System Markers Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Nervous System Markers Sales Value, 2019-2030
5.4.2 North America Nervous System Markers Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Nervous System Markers Sales Value, 2019-2030
5.5.2 Europe Nervous System Markers Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Nervous System Markers Sales Value, 2019-2030
5.6.2 Asia Pacific Nervous System Markers Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Nervous System Markers Sales Value, 2019-2030
5.7.2 South America Nervous System Markers Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nervous System Markers Sales Value, 2019-2030
5.8.2 Middle East & Africa Nervous System Markers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nervous System Markers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nervous System Markers Sales Value
6.2.1 Key Countries/Regions Nervous System Markers Sales Value, 2019-2030
6.2.2 Key Countries/Regions Nervous System Markers Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Nervous System Markers Sales Value, 2019-2030
6.3.2 United States Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nervous System Markers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nervous System Markers Sales Value, 2019-2030
6.4.2 Europe Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nervous System Markers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nervous System Markers Sales Value, 2019-2030
6.5.2 China Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nervous System Markers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nervous System Markers Sales Value, 2019-2030
6.6.2 Japan Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nervous System Markers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nervous System Markers Sales Value, 2019-2030
6.7.2 South Korea Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nervous System Markers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nervous System Markers Sales Value, 2019-2030
6.8.2 Southeast Asia Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nervous System Markers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nervous System Markers Sales Value, 2019-2030
6.9.2 India Nervous System Markers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nervous System Markers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Athena Diagnostics
7.1.1 Athena Diagnostics Company Information
7.1.2 Athena Diagnostics Introduction and Business Overview
7.1.3 Athena Diagnostics Nervous System Markers Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Athena Diagnostics Nervous System Markers Product Offerings
7.1.5 Athena Diagnostics Recent Development
7.2 Myriad RBM
7.2.1 Myriad RBM Company Information
7.2.2 Myriad RBM Introduction and Business Overview
7.2.3 Myriad RBM Nervous System Markers Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Myriad RBM Nervous System Markers Product Offerings
7.2.5 Myriad RBM Recent Development
7.3 QIAGEN
7.3.1 QIAGEN Company Information
7.3.2 QIAGEN Introduction and Business Overview
7.3.3 QIAGEN Nervous System Markers Sales, Revenue and Gross Margin (2019-2024)
7.3.4 QIAGEN Nervous System Markers Product Offerings
7.3.5 QIAGEN Recent Development
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Information
7.4.2 Thermo Fisher Scientific Introduction and Business Overview
7.4.3 Thermo Fisher Scientific Nervous System Markers Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Thermo Fisher Scientific Nervous System Markers Product Offerings
7.4.5 Thermo Fisher Scientific Recent Development
8 Industry Chain Analysis
8.1 Nervous System Markers Industrial Chain
8.2 Nervous System Markers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nervous System Markers Sales Model
8.5.2 Sales Channel
8.5.3 Nervous System Markers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Athena Diagnostics
Myriad RBM
QIAGEN
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.